Central Trust CO Edwards Lifesciences Corp Transaction History

Central Trust CO

$4.19 Billion
Q3 2024

A detailed history of Central Trust CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Central Trust CO holds 2,553 shares of EW stock, worth $172,991. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,553

Previous 3,908 34.67%

Holding current value

$172,991

Previous $360,000 53.33%

% of portfolio

0.0%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$59.7 - $93.78 $80,893 - $127,071	-1,355 Reduced 34.67%	2,553 $168,000
Q1 2024 Apr 24, 2024	BUY	$72.54 - $95.56 $23,648 - $31,152	326 Added 9.1%	3,908 $373,000
Q4 2023 Jan 24, 2024	SELL	$61.71 - $77.76 $5,492 - $6,920	-89 Reduced 2.42%	3,582 $273,000
Q3 2023 Oct 26, 2023	BUY	$69.28 - $93.38 $1,662 - $2,241	24 Added 0.66%	3,671 $254,000
Q2 2023 Jul 26, 2023	BUY	$81.41 - $94.33 $78,967 - $91,500	970 Added 36.23%	3,647 $344,000
Q1 2023 Apr 19, 2023	SELL	$74.26 - $84.51 $1,782 - $2,028	-24 Reduced 0.89%	2,677 $221,000
Q4 2022 Jan 26, 2023	BUY	$68.3 - $87.44 $96,303 - $123,290	1,410 Added 109.22%	2,701 $0
Q3 2022 Nov 17, 2022	BUY	$82.37 - $107.29 $3,294 - $4,291	40 Added 3.2%	1,291 $107,000
Q2 2022 Aug 09, 2022	SELL	$86.5 - $128.27 $52,505 - $77,859	-607 Reduced 32.67%	1,251 $119,000
Q1 2022 May 03, 2022	SELL	$101.96 - $128.34 $815 - $1,026	-8 Reduced 0.43%	1,858 $218,000
Q4 2021 Feb 08, 2022	BUY	$106.37 - $130.68 $21,805 - $26,789	205 Added 12.34%	1,866 $241,000
Q3 2021 Oct 19, 2021	BUY	$102.91 - $122.75 $17,906 - $21,358	174 Added 11.7%	1,661 $188,000
Q2 2021 Jul 23, 2021	BUY	$83.84 - $104.76 $3,605 - $4,504	43 Added 2.98%	1,487 $154,000
Q4 2020 Jan 29, 2021	BUY	$71.69 - $91.23 $7,169 - $9,123	100 Added 7.44%	1,444 $131,000
Q2 2020 Jul 14, 2020	BUY	$57.54 - $76.95 $51,555 - $68,947	896 Added 200.0%	1,344 $92,000
Q4 2019 Jan 21, 2020	SELL	$71.7 - $82.09 $15,200 - $17,403	-212 Reduced 32.12%	448 $34,000
Q3 2019 Oct 28, 2019	SELL	$61.55 - $75.43 $615 - $754	-10 Reduced 1.49%	660 $145,000
Q2 2018 Jul 09, 2018	BUY	$42.45 - $51.3 $1,443 - $1,744	34 Added 5.35%	670 $0
Q4 2017 Jan 23, 2018	BUY	$33.79 - $39.39 $2,905 - $3,387	86 Added 15.64%	636 $0
Q3 2017 Oct 17, 2017	BUY	$36.29 - $38.83 $19,959 - $21,356	550	550 $0

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.

Account